cetirizine has been researched along with Bronchial Hyperreactivity in 8 studies
Cetirizine: A potent second-generation histamine H1 antagonist that is effective in the treatment of allergic rhinitis, chronic urticaria, and pollen-induced asthma. Unlike many traditional antihistamines, it does not cause drowsiness or anticholinergic side effects.
cetirizine : A member of the class of piperazines that is piperazine in which the hydrogens attached to nitrogen are replaced by a (4-chlorophenyl)(phenyl)methyl and a 2-(carboxymethoxy)ethyl group respectively.
Bronchial Hyperreactivity: Tendency of the smooth muscle of the tracheobronchial tree to contract more intensely in response to a given stimulus than it does in the response seen in normal individuals. This condition is present in virtually all symptomatic patients with asthma. The most prominent manifestation of this smooth muscle contraction is a decrease in airway caliber that can be readily measured in the pulmonary function laboratory.
Excerpt | Relevance | Reference |
---|---|---|
"Fifteen atopic asthmatics were randomized in double-blind, cross-over fashion to receive for 1 week either levocetirizine 5 mg or placebo." | 9.11 | Single and short-term dosing effects of levocetirizine on adenosine monophosphate bronchoprovocation in atopic asthma. ( Gray, RD; Lee, DK; Lipworth, BJ; Robb, FM; Soutar, PC; Wilson, AM, 2004) |
"Cetirizine is a non-sedating H1 antihistamine which is effective in the treatment of allergic rhinitis and urticaria." | 6.68 | A comparison of the effects of oral cetirizine and inhaled beclomethasone on early and late asthmatic responses to allergen and the associated increase in airways hyperresponsiveness. ( Bentley, AM; De Vos, C; Durham, SR; Hanotte, F; Walker, S, 1996) |
"Fifteen atopic asthmatics were randomized in double-blind, cross-over fashion to receive for 1 week either levocetirizine 5 mg or placebo." | 5.11 | Single and short-term dosing effects of levocetirizine on adenosine monophosphate bronchoprovocation in atopic asthma. ( Gray, RD; Lee, DK; Lipworth, BJ; Robb, FM; Soutar, PC; Wilson, AM, 2004) |
"Cetirizine is a non-sedating H1 antihistamine which is effective in the treatment of allergic rhinitis and urticaria." | 2.68 | A comparison of the effects of oral cetirizine and inhaled beclomethasone on early and late asthmatic responses to allergen and the associated increase in airways hyperresponsiveness. ( Bentley, AM; De Vos, C; Durham, SR; Hanotte, F; Walker, S, 1996) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (37.50) | 18.2507 |
2000's | 4 (50.00) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Delescluse, I | 1 |
Mace, H | 1 |
Adcock, JJ | 1 |
Magnan, A | 1 |
Lee, DK | 1 |
Gray, RD | 1 |
Wilson, AM | 1 |
Robb, FM | 1 |
Soutar, PC | 1 |
Lipworth, BJ | 1 |
Boichot, E | 1 |
Richard, MP | 1 |
Paubert-Braquet, M | 1 |
Bentley, AM | 1 |
Walker, S | 1 |
Hanotte, F | 1 |
De Vos, C | 1 |
Durham, SR | 1 |
Aubier, M | 2 |
Musoh, K | 1 |
Maeda, Y | 1 |
Tanaka, H | 1 |
Inagaki, N | 1 |
Nagai, H | 1 |
Neukirch, C | 1 |
Peiffer, C | 1 |
Melac, M | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
A Placebo Controlled Trial to Evaluate The Effects of Levocetirizine on Nasal Allergen Challenge And Adenosine Monophosphate Challenge In Patients With Intermittent and Persistent Allergic Rhinitis[NCT00679250] | Phase 4 | 25 participants (Actual) | Interventional | 2005-11-30 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 review available for cetirizine and Bronchial Hyperreactivity
Article | Year |
---|---|
Linking upper and lower airways.
Topics: Adrenal Cortex Hormones; Bronchial Hyperreactivity; Cetirizine; Histamine H1 Antagonists; Humans; Rh | 1999 |
3 trials available for cetirizine and Bronchial Hyperreactivity
Article | Year |
---|---|
Single and short-term dosing effects of levocetirizine on adenosine monophosphate bronchoprovocation in atopic asthma.
Topics: Adenosine Monophosphate; Adult; Aged; Asthma; Bronchial Hyperreactivity; Bronchial Provocation Tests | 2004 |
A comparison of the effects of oral cetirizine and inhaled beclomethasone on early and late asthmatic responses to allergen and the associated increase in airways hyperresponsiveness.
Topics: Administration, Inhalation; Administration, Oral; Adult; Allergens; Antigens, Dermatophagoides; Asth | 1996 |
Effect of cetirizine on bronchial hyperresponsiveness in patients with seasonal allergic rhinitis and asthma.
Topics: Adult; Anti-Allergic Agents; Asthma; Bronchial Hyperreactivity; Bronchoconstrictor Agents; Cetirizin | 2001 |
4 other studies available for cetirizine and Bronchial Hyperreactivity
Article | Year |
---|---|
Inhibition of airway hyper-responsiveness by TRPV1 antagonists (SB-705498 and PF-04065463) in the unanaesthetized, ovalbumin-sensitized guinea pig.
Topics: Adrenergic beta-2 Receptor Agonists; Albuterol; Allergens; Animals; Atropine; Bronchial Hyperreactiv | 2012 |
[Respiratory allergies in the child and the adult].
Topics: Administration, Oral; Adrenal Cortex Hormones; Adult; Age Factors; Aged; Allergens; Anti-Allergic Ag | 2004 |
Effect of cefadroxil on antigen-induced bronchial hyperresponsiveness and eosinophil accumulation in lung from sensitized guinea pigs.
Topics: Acetylcholine; Aerosols; Animals; Bronchial Hyperreactivity; Cefadroxil; Cetirizine; Eosinophils; Gu | 1993 |
Effect of a novel anti-allergic agent, HSR-609, on antigen-induced airway hyperresponsiveness in mice.
Topics: Acetylcholine; Animals; Anti-Allergic Agents; Anti-Inflammatory Agents; Benzoxepins; Bronchial Hyper | 2000 |